The BIOVESTA Group of Companies produces “Biovestin,” a liquid probiotic with live active bifidobacteria with its own patented technology. This technology preserves the vital activity of the probiotic microorganisms in hermetically sealed 12 ml vials for up to 3 months with no noticeable decline in the concentration, while preventing contamination from foreign or pathogenic bacteria. Even at the end of its shelf life, the bifidobacteria concentration in “Biovestin” is never less than 5*10 in 8 cells per 1 ml.
While dry probiotics in capsules and powders are slow to take effect, “Biovestin” liquid probiotics have a greater positive impact on your health and well-being and get to work as soon as you take them. There are 3 reasons why:
- The microorganisms are alive and active. They have not entered a state of suspended animation because they have not been dehydrated (as is the case for dry probiotics).
- In liquid probiotics, the concentration of probiotic bacteria is at least 10 times higher than in dry probiotics as there are none of the damaging effects caused by dehydration.
- Living liquid probiotics contain metabolites, which are a product of the vital activity of bacteria and are good for our health, including B vitamins and volatile organic acids.
“Biovestin” living liquid probiotics have been proven effective by numerous clinical trials. The positive effects of taking “Biovestin” have been the focus of over 15 research dissertations.
BIOVESTA was founded in 1994 by employees of the State Research Centre of Virology and Biotechnology VECTOR, in Koltsovo (Novosibirsk Oblast). We have been producing restorative microflora for 25 years. “Biovestin” living liquid probiotics are sold in Russia, Kazakhstan, Kyrgyzstan, and Bulgaria.
We are open to working with pharmaceutical companies and eager to share our technology, know-how, and clinical research with the scientific community. Contact us by email at avg@biovesta.ru (Anna Golubyatnikova).
Company Details
- Employees
- 1
- Founded
- -
- Address
- Lesosechnaya Ulitsa, 3/1,russian Federation
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://biovestin.eu
- Keywords
- Probiotics, Restorative microflora, Microbiome health, Bifidobacteria, Pharmaceutical production, pharmaceutical manufacturing, Lactobacteria, Sinbiotics, Metabiotics, Human microbiome, Endoecology.
- HQ
- Novosibirsk
Biovesta Questions
Biovesta's website is https://biovestin.eu
Biovesta's LinkedIn profile is https://ru.linkedin.com/company/biovesta
Biovesta has
1 employees.
View email and phone details for 1
employees at Biovesta.
Biovesta's industry is
Pharmaceutical Manufacturing
Biovesta's top competitors are
Teva Pharmaceuticals,
Almedis Cro In Russia,
Indo Uk Institute Of Health,
Suzhou Tianma Pharma Group,
Acino,
Biovista Lifesciences Sdn Bhd,
Bioscience Innova,
Niltorg Llc,
Association Inpharma,
Heel Russia.
Biovesta's categories are Pharmaceutical Manufacturing
Biovesta's founding year is 1994
